期刊
NATURE REVIEWS GENETICS
卷 12, 期 1, 页码 69-73出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrg2920
关键词
-
资金
- NIGMS NIH HHS [U01 GM061374-10, U01 GM061374] Funding Source: Medline
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061374] Funding Source: NIH RePORTER
Tools such as genome resequencing and genome-wide association studies have recently been used to uncover a number of variants that affect drug toxicity and efficacy, as well as potential drug targets. But how much closer are we to incorporating pharmacogenomics into routine clinical practice? Five experts discuss how far we have come, and highlight the technological, informatics, educational and practical obstacles that stand in the way of realizing genome-driven medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据